Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Segment Income — Specialty Diagnostics by Year
Segment Income — Specialty Diagnostics ($M)
Thermo Fisher Scientific Segment Income — Specialty Diagnostics: $1,256M in FY2025, up 8.4% from a year earlier.
Where the FY2025 figure comes from
“SD: Segment income 304 306 321 324 1,256 313 334 341”
Source: Q3 2026 Reconciliation of Financial Information ↗
Full breakdown of external/intersegment revenues, Cost of Revenues, SG&A, R&D, Operating Assets (AR + Inventory), CapEx, and Depreciation under the new ASU 2023-07 accounting standard.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Segment Income — Specialty Diagnostics ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,256 | +8.4% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 1,159 | +3.1% | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 1,124 | +9.8% | Q4 & FY2024 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 1,024 | – | SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗ |
Breakdown
What makes up segment Income — Specialty Diagnostics
- Segment Income Margin — Specialty Diagnostics26.9% · FY2025
- Margin Expansion (percentage points) — Specialty Diagnostics1.2% · FY2025
- Doanh thu khách hàng bên ngoài (External Customer Revenues — Note 11) — Specialty Diagnostics4,604 · FY2025
- Intersegment Revenues — Note 11 — Specialty Diagnostics72 · FY2025
- Segment Cost of Revenues — ASU 2023-07 — Specialty Diagnostics2,718 · FY2025
- Segment SG&A — ASU 2023-07 — Specialty Diagnostics708 · FY2025
- Segment R&D Expense — ASU 2023-07 — Specialty Diagnostics178 · FY2025
- Segment Assets: AR + Inventory — Specialty Diagnostics1,323 · FY2025
- Segment Purchases of PP&E — Specialty Diagnostics128 · FY2025
- Segment Depreciation — Specialty Diagnostics91 · FY2025
- Goodwill — Specialty Diagnostics5,076 · FY2025
Cite this data
StockData. (2026). Thermo Fisher Scientific Segment Income — Specialty Diagnostics ($M), annual FY2022–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg-income-sd
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.